MOMENTA PHARMACEUTICALS JUMPS ON COPAXONE RULING, TAKE PROFITS AND EXIT THE POSITION IF STILL HOLDING $MNTA $MYL $TEVA

MOMENTA PHARMACEUTICALS JUMPS ON COPAXONE RULING, TAKE PROFITS AND EXIT THE POSITION IF STILL HOLDING $MNTA $MYL $TEVA

This post was published on ZYX Buy Change Alert.

MNTA has an average price of $11.31.  As of this writing it is trading at $19.05. The stock has jumped on a court invalidating TEVA patent on a MS drug Copaxone.  This was part of the original thesis to buy MNTA.  MYL is the other beneficiary.

The stock previously hit the target zone but not the upper band of the target zone until yesterday.  It appears that many subscribers are still holding. Consider taking profits on the position, if still holding, in the zone of $18.43 to $20.88 and exit the position.  As a reminder, if trying to wait for a higher price to exit, please be sure to put protective stops right under the low band of the new target zone.

Trades posted on The Arora Report Market Blog have produced unrivalled performance since 2007.  Please click here and scroll down to see the table of all trades.  These trades have been scrutinized in real-time by thousands of subscribers across the globe.  This provides easy verification of performance for newcomers to this site.  Only those trades are included in the performance where the entry post was made available to subscribers to The Arora Report Market Blog.  When the entry post is made available only to the paying subscribers and not posted in real-time on The Arora Report Market Blog, the resulting performance of the trade is not credited in the performance table.  There are very nice gains on this trade but since the entry trade was not posted here in real-time, handsome profits on this trade will not be added to the performance of The Arora Report Market Blog shown on the table.

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

BE FOREWARNED IF YOU ARE CHASING DIVIDENDS $TEVA $MYL $PRGO $RDY $ABX $MCK $CAH $ESRX

  Dividend-chasing is in vogue. Given low interest rates, many investors say they have no other choice. Such thinking leads to costly ...

TRUMP’S ‘OBAMACARE LITE’ PRESENTS OPPORTUNITIES AND PERILS FOR INVESTORS $XBI $MDT $BSX $EW $CYH $THC $PFE $JNJ $MRK $BMY $TEVA $MYL

Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside ...

TAKE PARTIAL PROFITS ON MYLAN $MYL

This post was just published on ZYX Buy Change Alert. MYL is long from an average price of $37.78.  As of this writing ...

A NEW IDEA ON MOMENTA, AFTER RECENT GAIN OF 74% THE DIP IS AN OPPORTUNITY TO ENTER AGAIN $MNTA $TEVA $PFE

This post was just published on ZYX Buy Change Alert. On February 1st we issued a call to take profits on MNTA.  Depending ...

MYLAN BENEFITING FROM COPAXONE $MYL $TEVA

This post was just published on ZYX Buy Change Alert. MYL is benefiting from invalidation of TEVA patent on Copaxone, an MS drug.  ...

REDUCE MYLAN ON TRUMP COMMENT $MYL

This post was published on ZYX Buy Change Alert.  Consider reducing MYL position to 30% of the full core position size if holding ...

HOW THE ‘JANUARY EFFECT’ IN STOCKS CAN HELP YOU POCKET QUICK GAINS $CYH $FIT $KANG $MYL $VRX $THC $HCA

  The so-called January Effect offers an opportunity to potentially make about 30% in three months in the stock market. The ...

PLAN ON MYLAN: TEVA PHARMACEUTICAL, TAX LOSS SELLING AND TRUMP $MYL $TEVA

This post was just published on ZYX Buy Change Alert. TEVA MYL is a generic drug manufacturer.  The earlier decline in the stock was ...

SMART MONEY LIGHTLY STEPS INTO MYLAN $MYL $ENDP $IPXL $LCI $TARO $TEVA

This post was just published on ZYX Buy Change Alert. Algorithms at The Arora Report have been detecting smart money lightly stepping into ...

UPDATE ON MYLAN $MYL $TEVA $LCI $IPXL $ENDP $TARO

This post was just published on ZYX Buy Change Alert. All generic drug manufacturers are falling on the news that U. S. prosecutors ...

MYLAN UP ABOUT 10% ON DOJ SETTLEMENT $MYL

This post was just published on ZYX Buy Change Alert. MYL has reached a $465 million settlement with the Department of Justice on ...

INITIATE OR ADD TO MYLAN $MYL

This post was just published on ZYX Buy Change Alert. MYL is long from an average price of $38.47.  As of this writing ...

UPDATE ON MYLAN LABS $MYL

This post was just published on ZYX Buy Change Alert. MYL is falling again on news of a Senator posting on her ...

A NEW IDEA ON MYLAN LABS $MYL

This post was just published on ZYX Buy Change Alert. MYL is primarily a drug manufacturer but also has a few branded ...

GET AHEAD OF SUPREME COURT ON OBAMACARE, TAKE PROFITS AND REVIEW HEALTHCARE POSITIONS $CYH $THC $RAD $WBA $MOH $CNC $PRGO $MYL #OBAMACARE

This post was just published on ZYX Buy Change Alert. The Supreme Court is likely to make a ruling on Obamacare this ...

SMART MONEY SELLS INTO MYLAN RISE FOR A GOOD REASON $MYL $FRX $ACT $TEVA

Since the Feb. 18 announcement that Actavis would acquire Forest Laboratories for about $25 billion, which caused Forest Laboratories stock to leap ...

CUBIST PHARMACEUTICALS (CBST) ACQUISITION TARGET

Yesterday Cubist (CBST) settled its long running dispute with Teva Pharmaceuticals (TEVA). It appears that this development sets Cubist up to be ...

Follow

Get every new post delivered to your Inbox

Join other followers